Buy Oseltamivir (Tamiflu) tablets online
(trade names include Tamiflu, Antiflu, Fluhalt, Fluvir, GPO-A-Flu, Rimivat
) is an antiviral medication from neuraminidase inhibitors pharmacological group. This medicine is used for the treatment and prevention of influenza A and influenza B (flu). It works by blocking the actions of influenza virus types A and B in your body.
How and where to order Oseltamivir (Tamiflu) 75 mg tablets online:
: BUY OSELTAMIVIR ONLINE
from $5.16 per pill
5% coupon: 5OFF
Oseltamivir (Tamiflu) 75 mg tablets
10, 20, 30, 60, 90 pills
Tamiflu (Oseltamivir) generic
Visa, MasterCard, AmEx, JCB, Bitcoin
Unregistered Mail or Trackable Courier
Worldwide, including USA, UK, Europe, Canada, Australia
Pharmacological and medical categories:
Anti flu medicines
Influenza's neuraminidase enzyme inhibitors
J - Antiinfectives for systemic use
J05 - Antivirals for systemic use
J05A - Direct acting antivirals
J05AH - Neuraminidase inhibitors
J05AH02 - Oseltamivir
Influenza due to certain identified influenza viruses - J09
B1 - Australia
C - United States (Risk cannot be ruled out)
Salts and other forms:
Synonyms, international and chemical names:
Brands, generics, trade names:
Antiflu - Cipla
Fluhalt - Ranbaxy, Pharmaniaga
Fluvir - Hetero Healthcare
GPO-A-Flu - The Government Pharmaceutical Organization
Rimivat - Andromaco Laboratorios
Tamiflu - Roche, Genentech, Gilead
Indications and usage:
Tamiflu (Oseltamivir) is an influenza neuraminidase inhibitor (NAI) indicated for:
Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours.
Prophylaxis of influenza A and B in patients 1 year and older.
Limitations of Use:
Not a substitute for annual influenza vaccination.
Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use.
Not recommended for patients with end-stage renal disease not undergoing dialysis.
Dosage and administration:
Treatment of influenza
Adults and adolescents (13 years and older): 75 mg twice daily for 5 days
Pediatric patients 1 to 12 years of age: Based on weight twice daily for 5 days
Pediatric patients 2 weeks to less than 1 year of age: 3mg/kg twice daily for 5 days
Renally impaired adult patients (creatinine clearance > 30-60 mL/min): Reduce to 30 mg twice daily for 5 days
Renally impaired adult patients (creatinine clearance >10-30 mL/min): Reduce to 30 mg once daily for 5 days
ESRD patients on hemodialysis: Reduce to 30 mg immediately and then 30 mg after every hemodialysis cycle. Treatment duration not to exceed 5 days
ESRD patients on CAPD: Reduce to a single 30 mg dose immediately
Prophylaxis of influenza
Adults and adolescents (13 years and older): 75 mg once daily for at least 10 days
Community outbreak: 75 mg once daily for up to 6 weeks
Pediatric patients 1 to 12 years of age: Based on weight once daily for 10 days
Community outbreak: Based on weight once daily for up to 6 weeks
Renally impaired adult patients (creatinine clearance >30-60 mL/min): Reduce to 30 mg once daily
Renally impaired adult patients (creatinine clearance >10-30 mL/min): Reduce to 30 mg once every other day
ESRD patients on hemodialysis: Reduce to 30 mg immediately and then 30 mg after alternate hemodialysis cycles for the recommended duration of prophylaxis
ESRD patients on CAPD: Reduce to 30 mg immediately and then 30 mg once weekly for the recommended duration of prophylaxis
Dosage forms and strengths:
Tamiflu (Oseltamivir) capsules: 30 mg, 45 mg, 75 mg
For oral suspension: 360 mg oseltamivir base supplied as powder (constituted to a final concentration of 6 mg/mL)
Patients with known serious hypersensitivity to oseltamivir or any of the components of Tamiflu
Warnings and precautions:
Serious skin/hypersensitivity reactions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis and erythema multiforme: Discontinue Tamiflu and initiate appropriate treatment if allergic-like reactions occur or are suspected.
Neuropsychiatric events: Patients with influenza, including those receiving Tamiflu (Oseltamivir), particularly pediatric patients, may be at an increased risk of confusion or abnormal behavior early in their illness. Monitor for signs of abnormal behavior.
Adverse reactions, side effects:
Most common adverse reactions ( > 1% and more common than with placebo):
Treatment studies - nausea, vomiting, headache.
Prophylaxis studies - nausea, vomiting, headache, pain.
Live attenuated influenza vaccine (LAIV), intranasal:
Avoid administration of LAIV within 2 weeks before or 48 hours after Oseltamivir (Tamiflu) use, unless medically indicated.
Updated: February 2020
Reviewed: February 2020
"We provided some exciting changes to the study plan within a couple of weeks of treatment dates and the team stepped up, as usual, and put a plan into place to give us the highest chance of success utilizing the criteria we requested."
Our expert preclinical Surgeons and Interventionalists can assist with human factors assessments and evaluating prototypes for your GLP or nonGLP preclinical studies.